The CenterWatch Monthly, October 2012

Monday, October 1, 2012 01:22 PM

CRCs workload up: relative pay declining

Clinical research coordinators (CRCs), widely considered the “glue” that holds clinical projects together at investigative sites, report that the volume of studies they manage on an annual basis has nearly doubled during the past decade, yet salary levels during this same period have remained flat, according to a new CenterWatch survey. Nearly 70% of the 269 study coordinators who participated in the survey—the first new CenterWatch analysis of the CRC workforce in a decade—also report a significant increase in their responsibilities, as clinical studies have become more complex and budget constraints have taken a toll on investigative sites. Surprisingly, despite this increasing workload, the turnover rate among CRCs has…

 

As IRB industry grows up, consolidation comes knocking

As various unforgiving market forces sweep through all sectors of the drug development world, we’ve seen some interesting changes in the IRB space in the last year. These shifts represent the various ways in which consolidation is now sweeping through the small but vital sector of the research enterprise, according to noted bioethicist Art Caplan. There’s the IRB closing, the IRB acquired by another IRB and the IRB purchased by an investor group…

 

Eye on Boehringer Ingelheim

Boehringer Ingelheim is a globally affiliated group of 145 companies founded and headquartered in Germany. Currently, it employs more than 44,000, including 7,000 in research and development. To design new therapies for diseases with an unmet therapeutic need, Boehringer Ingelheim focuses heavily on R&D, not only internally but also through external collaborations…

 

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs